Finasteride + Minoxidil Hair Loss Treatment | BIOELITE Hormone Health and Wellness

Finasteride and Minoxidil for androgenetic alopecia (hair loss). Medically supervised, FDA-recognized treatments to slow hair loss and support regrowth.

FINASTERIDE + MINOXIDIL

Two clinically studied treatments, working through different mechanisms, to help slow hair loss and support regrowth.

Androgenetic alopecia — commonly known as male pattern hair loss — affects roughly half of men by their 50s. Finasteride and Minoxidil are the two most studied medications for it, and they work in different ways: Finasteride addresses the hormonal driver behind hair follicle miniaturization, while Minoxidil works locally at the scalp to support blood flow and extend the hair growth cycle. Used together, they target two separate mechanisms behind hair loss. Treatment is medically supervised, starting with a consultation to determine what's appropriate for you.

HOW IT WORKS

Finasteride is a 5-alpha reductase inhibitor. It works by blocking the enzyme that converts testosterone into dihydrotestosterone (DHT) — the hormone primarily responsible for shrinking hair follicles over time in genetically susceptible men. Oral finasteride (1 mg) is FDA-approved for male pattern hair loss and has been studied for over three decades. In clinical studies, oral finasteride reduces DHT levels significantly in the bloodstream and scalp. Some patients are prescribed a compounded topical formulation instead; there is currently no FDA-approved topical finasteride product, so topical formulations are compounded to your specific prescription (more on this under Safety Information below).

Minoxidil is a vasodilator that works locally at the scalp. It's believed to increase blood flow to hair follicles and extend the "anagen" (growth) phase of the hair cycle, allowing more hairs to grow longer before shedding. Topical minoxidil (typically 5% solution or foam) is FDA-approved for androgenetic alopecia. Low-dose oral minoxidil is increasingly prescribed off-label as an alternative for patients who find daily topical application inconvenient or who don't respond well to it.

Primarily used for:

Male Pattern Hair Loss (Androgenetic Alopecia):

The FDA-recognized indication for both oral finasteride and topical minoxidil. This is the primary reason most patients start treatment.

Slowing Further Hair Loss:

Both medications are best understood as working to slow or stop the progression of thinning, rather than guaranteeing regrowth in areas that have been bald for a long time.

Supporting Regrowth in Early-to-Moderate Thinning:

Patients who start treatment earlier in the thinning process, particularly at the crown and mid-scalp, tend to see the most noticeable results.

A Combined-Mechanism Approach:

Because Finasteride addresses the hormonal cause and Minoxidil supports the follicle locally, using them together targets hair loss from two different angles rather than relying on a single mechanism.

Benefits:

Backed by Decades of Clinical Study:

Both medications have been studied since the 1990s, with an extensive body of research behind their use for androgenetic alopecia.

Complementary Mechanisms:

Addressing both the hormonal (DHT) and local (blood flow/growth cycle) drivers of hair loss in one protocol.

Multiple Formulation Options:

Oral and topical forms are available, allowing your protocol to be tailored to your preference and medical history.

Medically Supervised Dosing:

Your protocol is determined by a licensed provider based on your history, goals, and any relevant lab work — not a one-size-fits-all regimen.

IMPORTANT SAFETY INFORMATION

Finasteride — reported side effects:

Sexual side effects (reduced libido, erectile dysfunction, decreased ejaculate volume) have been reported in a small percentage of users in clinical trials.

The FDA requires finasteride labeling to include warnings for depression and, since 2022, suicidal ideation and behavior. If you have a history of depression or mood-related concerns, this is important to discuss with your provider before starting.

A subset of patients have reported sexual, neurological, or psychological symptoms that persisted after stopping finasteride — sometimes referred to as "post-finasteride syndrome." This isn't an officially recognized diagnosis, and how often it actually occurs is debated, but it's a real concern some patients raise, and worth discussing candidly with your provider.

Rare reports of breast tenderness or enlargement have been noted.

Finasteride lowers PSA (prostate-specific antigen) levels by roughly half — if you have PSA testing done for any reason, make sure whoever orders it knows you're taking finasteride.

Finasteride must not be handled by anyone who is or may become pregnant. It can cause birth defects in a male fetus if absorbed through the skin, including from broken or crushed tablets.

Topical finasteride specifically: there is currently no FDA-approved topical finasteride product — any topical formulation is compounded to your prescription. In 2025 the FDA issued a safety alert on compounded topical finasteride, noting risks of local skin irritation and the possibility of inadvertent exposure to others (particularly female partners or family members) through skin contact with treated areas. We're including this here because we'd rather you hear it from us than find it on your own after starting.

Minoxidil — reported side effects:

Scalp itching, irritation, or dryness are the most common issues with topical use.

Unwanted hair growth on the face or other parts of the body (hypertrichosis) has been reported, more commonly with oral use than topical.

A temporary increase in shedding is common in the first 2–8 weeks of starting minoxidil. This is usually a normal part of the hair cycle resetting, not a sign the treatment is failing — but let your provider know if it doesn't resolve.

Oral minoxidil was originally developed as a blood pressure medication at much higher doses. At the low doses used for hair loss, side effects are uncommon but can include lightheadedness, fluid retention, or a faster heartbeat. It may not be appropriate for patients with certain heart conditions without medical clearance first.

Low-dose oral minoxidil for hair loss is an off-label use — effective and widely prescribed by dermatologists, but not an FDA-approved indication for the oral form.

This protocol may not be right for you if you are pregnant, breastfeeding, or may become pregnant; have a history of significant depression or suicidal ideation; have significant heart disease (relevant to oral minoxidil); or have had a prior serious reaction to either medication. Your consultation and intake will screen for these before anything is prescribed.

Conclusion:

Finasteride and Minoxidil remain the two best-studied treatments for androgenetic alopecia, working through complementary mechanisms to slow hair loss and support regrowth. They're not right for everyone, and results vary by individual — which is why treatment starts with a consultation with a licensed provider to review your history and determine what's appropriate for you, with follow-up to monitor how you're responding.